A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis

Clinical trial NCT01922843 · COMPLETED

Trial details

NCT number: NCT01922843
Sponsor: Deltanoid Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperparathyroidism, Secondary Kidney Failure, Chronic

Start date: 2013-09-01
Primary completion: 2014-05-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.